The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition - Tseng, P L; Chen, C W; Hu, K H (Oncotarget, 2018)
et al.